Walgreens, recently acquired by the private equity firm Sycamore Partners, is undergoing significant restructuring that includes laying off hundreds of employees across multiple states. The cuts, impacting both its distribution network and corporate headquarters, signal a shift in strategy for the drugstore chain as it aims to streamline operations and improve customer experience. This news follows a period of financial challenges and strategic changes for Walgreens, raising concerns about the future of the company and its workforce.
The layoffs, first reported on February 20, 2026, will affect at least 600 workers. A notice filed with the state of Texas on February 12, 2026, details the elimination of 159 positions due to the closure of the company’s distribution center in Houston, with the effective date set for June 1, 2026. 469 employees at Walgreens’ headquarters in Illinois will be impacted, according to a separate notice filed with the state on February 10, 2026. These actions represent a substantial reduction in the company’s workforce and a significant change in its operational footprint.
Walgreens’ Restructuring Under New Ownership
The layoffs approach approximately five months after Sycamore Partners formally completed its $10 billion acquisition of Walgreens in September 2025. Following the acquisition, Walgreens was reorganized into five independent entities, including the spin-off of The Boots Group, its international retail pharmacy chain. This restructuring is part of a broader effort by Sycamore Partners to improve efficiency and profitability within the company. A Walgreens spokesperson stated that the company is “focused on becoming America’s best retail pharmacy, beginning with improving the in-store experience for our customers and patients,” and that the organizational simplification is intended to “speed decision making and improve the service that millions of customers rely on every day.”
However, the restructuring has sparked criticism from labor advocates who fear that cost-cutting measures implemented by private equity firms often lead to job losses and reduced services. Jim Baker, executive director of the Private Equity Stakeholder Project (PESP), noted that the layoffs confirm concerns raised after initial cost-cutting measures, such as the elimination of paid holidays for hourly workers, were announced shortly after the acquisition. “This pattern is unfortunately familiar in private equity takeovers,” Baker stated, highlighting the common practice of prioritizing financial engineering over workforce stability.
Financial Pressures and Previous Restructuring Efforts
The acquisition by Sycamore Partners followed a period of financial difficulty for Walgreens. Prior to the sale, the company had been grappling with declining sales and store closures. In June 2025, Walgreens reported a 5.3% year-over-year decrease in front-of-store retail sales, largely attributed to store closures and lower comparable sales. This decline prompted the company to announce plans in 2024 to close 1,200 U.S. Stores over a three-year period, a move intended to reduce costs and streamline its retail operations. The company reported approximately 8,000 locations and 211,000 workers as of January 2026, down from 8,500 stores and 220,000 employees at the time the Sycamore Partners buyout closed in August 2025.
The appointment of former Staples US Retail CEO to lead Walgreens has also raised concerns, given his track record of store closures and layoffs during his tenure at Staples after a similar private equity acquisition. Sycamore Partners reportedly oversaw the closure of roughly one-third of Staples’ U.S. Stores and tens of thousands of layoffs while also adding debt to Staples’ balance sheet to extract a $1 billion dividend. This history suggests a similar approach may be implemented at Walgreens, prioritizing short-term financial gains over long-term investment in the workforce and customer experience.
Impact on Employees and Communities
The layoffs will have a significant impact on the affected employees and their communities. The closure of the Houston distribution center will leave 159 individuals without jobs, while the cuts at the Illinois headquarters will affect 469 employees. Walgreens has stated its commitment to supporting affected employees throughout the transition, but the long-term consequences of job losses on local economies remain a concern. The company has not yet released detailed information about severance packages or outplacement services that will be offered to those impacted.
The broader implications of these changes for Walgreens’ customers and the healthcare landscape are also uncertain. While the company aims to improve the in-store experience, reducing staff and closing distribution centers could potentially lead to longer wait times, reduced services, and limited access to essential medications and healthcare products. The success of Walgreens’ restructuring will depend on its ability to balance cost-cutting measures with the need to maintain quality customer service and ensure access to healthcare for communities across the country.
The Role of Private Equity in Healthcare
The Walgreens acquisition by Sycamore Partners is part of a growing trend of private equity investment in the healthcare industry. While private equity firms can bring capital and expertise to struggling companies, their focus on short-term profits often raises concerns about the potential for cost-cutting measures that could compromise patient care and workforce stability. Critics argue that private equity firms prioritize financial returns over the public good, leading to reduced access to healthcare services, increased prices, and lower quality of care.
The PESP has been a vocal critic of private equity’s involvement in healthcare, documenting numerous cases of companies acquired by private equity firms implementing cost-cutting measures that negatively impact patients and workers. The Walgreens situation serves as a cautionary tale, highlighting the potential risks associated with private equity ownership of essential healthcare providers. The coming months will be crucial in determining whether Sycamore Partners can successfully transform Walgreens while maintaining its commitment to providing accessible and affordable healthcare services.
The next significant development to watch will be Walgreens’ first-quarter earnings report under Sycamore Partners’ ownership, expected in late February 2026. This report will provide further insight into the company’s financial performance and the impact of the restructuring efforts. Readers can stay updated on the situation through official Walgreens press releases and financial filings, as well as reporting from reputable news sources like Reuters and the Associated Press.
What are your thoughts on the Walgreens restructuring? Share your comments below, and please share this article with your network.
Keep reading